AU514608B2 - 3,4-substituted-azetidin-z-ones - Google Patents

3,4-substituted-azetidin-z-ones

Info

Publication number
AU514608B2
AU514608B2 AU43899/79A AU4389979A AU514608B2 AU 514608 B2 AU514608 B2 AU 514608B2 AU 43899/79 A AU43899/79 A AU 43899/79A AU 4389979 A AU4389979 A AU 4389979A AU 514608 B2 AU514608 B2 AU 514608B2
Authority
AU
Australia
Prior art keywords
azetidin
ones
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU43899/79A
Other versions
AU4389979A (en
Inventor
John Gerald Gleason
Kenneth George Holden
William Francis Huffman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Corp filed Critical SmithKline Corp
Priority to AU43899/79A priority Critical patent/AU514608B2/en
Publication of AU4389979A publication Critical patent/AU4389979A/en
Application granted granted Critical
Publication of AU514608B2 publication Critical patent/AU514608B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
AU43899/79A 1975-05-05 1979-02-02 3,4-substituted-azetidin-z-ones Ceased AU514608B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU43899/79A AU514608B2 (en) 1975-05-05 1979-02-02 3,4-substituted-azetidin-z-ones

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US626686 1975-10-29
AU43899/79A AU514608B2 (en) 1975-05-05 1979-02-02 3,4-substituted-azetidin-z-ones
US574225 1984-01-26

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU13669/76A Division AU500636B2 (en) 1975-05-05 1976-05-05 Isocephalosporins and intermediates

Publications (2)

Publication Number Publication Date
AU4389979A AU4389979A (en) 1979-05-31
AU514608B2 true AU514608B2 (en) 1981-02-19

Family

ID=3731189

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43899/79A Ceased AU514608B2 (en) 1975-05-05 1979-02-02 3,4-substituted-azetidin-z-ones

Country Status (1)

Country Link
AU (1) AU514608B2 (en)

Also Published As

Publication number Publication date
AU4389979A (en) 1979-05-31

Similar Documents

Publication Publication Date Title
PH20254A (en) 1,2 dihydro-2-oxo-(pyridiny,) nicotinanide
AU510273B2 (en) 103-dihydroimidazo (4,5-6) pyridin -2-ones
AU504595B2 (en) 4,5-dihydro-2-lower-alkoxycarbonyl-amino-4 phenylimidazoles
AU498333B2 (en) 7-substituted-benzo-1, 2, 4-triazine-3-ethers
AU507882B2 (en) 1, 4-diphenyl-3-pyrazolin-5-ones
AU511134B2 (en) 3-Isoxazolylcarbamoyl-l, 2-benzothianzine 1, 1-dioxide
AU1214076A (en) 2,3-dihalogen-alkanoyl-ureas
AU502683B2 (en) Thiopyrano-4, 3-c-pyrazoles
AU500164B2 (en) 3, 4, 5-substituted benzenesulfonformamidines
AU518594B2 (en) 15, 15-dihydroxyprostaglandins
AU505725B2 (en) 2, 9-dioxatricyclo ( 4,3,1,03,70 dercanes
AU505161B2 (en) 1, 3, 5, 7-tetraaza-4-sulpha-hept-1-en-6-one derivatives
AU499442B2 (en) 1, 4 benzodioxanes
GB1483330A (en) 2,5-dimethoxy-4-chloroaniline
AU502268B2 (en) 2, 1, 3-benzothiadiazine compounds
AU511156B2 (en) 7, 7-Dimethylnorbornane derivatives
AU504998B2 (en) 1, 3, 5 oxadiazine derivatives
AU500501B2 (en) 6,11-dihydrodibenzo-thiepin-11-ones
AU1483576A (en) 16,16-dimethyl-prostaglandins
AU1724576A (en) 2,4-diamino-5-benzylpyrimidines
AU506542B2 (en) 1, 3-dialkyl-7-oxoalkylxanthines
AU506523B2 (en) 1, 3-Dialkyl-7-oxoalkylaxanthines
AU493823B2 (en) 1,1-diaryl-1-oxadiazol-alkylamines
AU514608B2 (en) 3,4-substituted-azetidin-z-ones
AU506546B2 (en) 3, 20-diketopregnenes having an 11b-acetal groups